Core B: Data and Research Methods

核心 B:数据和研究方法

基本信息

  • 批准号:
    10711727
  • 负责人:
  • 金额:
    $ 29.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2028-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary Despite their public health significance, interventions focusing on opioid use disorder and overdose often suffer from a lack of rigorous design and evaluation. Throughout phase II of the COBRE on Opioids & Overdose, the Data and Research Methods (DRM) Core will continue to support COBRE project leaders and pilot investigators in overcoming the methodological, analytical, and translational challenges that have traditionally stymied research project success and public health impact. By providing quantitative expertise, research infrastructure, and technological resources, the DRM Core greatly strengthens the rigor of the work produced by COBRE investigators, enhances their data use/management capacity, and provides training opportunities relevant to the entire research to practice pipeline. DRM Core services include: 1) methodological consultation on study design issues such as sampling, matching, survey development, and data harmonization; 2) biostatistical support, such as the use of statistical models, model-building procedures, model specification, and methods to handle missing data; 3) “dashboarding” and other visualization services to generate user-friendly, interactive data outputs for dissemination and translation of information; 4) providing a HIPAA-compliant data management system which will provide multi-tier access, back-ups, and de-identification; 5) providing access and linkage to statewide overdose-related databases, as well as record matching services to enrich outcomes across projects; and 6) providing training on and facilitating the exchange of methodological, computational, and analytic ideas related to the study of overdose and opioid-related harms. In phase II, the DRM Core will offer expertise on best practices for centering racial/ethnic health equity throughout all stages of the research process, and will support investigators as they apply open science principles to their work. DRM Core Director Dr. Brandon Marshall is an established CDC- and NIH-funded investigator with extensive experience in cohort study design, survey development, and the use of advanced quantitative methods, including simulation approaches, to evaluate non-randomized public health interventions. His leadership will be supplemented by highly trained staff with expertise in epidemiological methods, project management, database development, programming, data visualization, and biostatistics.
项目摘要 尽管它们具有公共卫生意义,但侧重于阿片类药物使用障碍和过量的干预措施往往受到影响, 缺乏严格的设计和评估。在COBRE关于阿片类药物和过量的第二阶段, 数据和研究方法(DRM)核心将继续支持COBRE项目领导人和试点研究人员 在克服传统上阻碍我们的方法论、分析和翻译挑战方面, 研究项目的成功和公共卫生的影响。通过提供定量的专业知识,研究基础设施, 和技术资源,DRM核心大大加强了COBRE工作的严谨性 调查员,提高他们的数据使用/管理能力,并提供与 整个研究到实践的管道。DRM核心服务包括:1)研究设计方法咨询 抽样、匹配、调查开发和数据协调等问题; 2)生物统计支持, 作为统计模型的使用,模型建立程序,模型规范,以及处理缺失的方法 数据; 3)“仪表板”和其他可视化服务,以生成用户友好的交互式数据输出, 信息的传播和翻译; 4)提供符合HIPAA的数据管理系统, 将提供多层访问,备份和去识别; 5)提供全州范围的访问和链接 过量相关的数据库,以及记录匹配服务,以丰富跨项目的成果;以及6) 提供培训,促进方法,计算和分析思想的交流, 过量服用和阿片类药物相关危害的研究。在第二阶段,数字版权管理核心将提供有关最佳做法的专门知识 在研究过程的各个阶段以种族/民族健康公平为中心,并将支持 研究人员将开放科学原则应用于他们的工作。 DRM核心主任布兰登马歇尔博士是一个既定的疾病预防控制中心和国家卫生研究院资助的研究人员与广泛的 在队列研究设计、调查开发和使用先进定量方法方面的经验,包括 模拟方法,以评估非随机公共卫生干预措施。他的领导将是 由在流行病学方法、项目管理、数据库、 开发、编程、数据可视化和生物统计学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brandon David Lewis Marshall其他文献

Brandon David Lewis Marshall的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brandon David Lewis Marshall', 18)}}的其他基金

DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)
DAT-18-06 使用优化的纳洛酮分配策略预防和救援芬太尼和其他阿片类药物过量(PROFOUND)
  • 批准号:
    10349581
  • 财政年份:
    2019
  • 资助金额:
    $ 29.33万
  • 项目类别:
DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)
DAT-18-06 使用优化的纳洛酮分配策略预防和救援芬太尼和其他阿片类药物过量(PROFOUND)
  • 批准号:
    9762301
  • 财政年份:
    2019
  • 资助金额:
    $ 29.33万
  • 项目类别:
DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)
DAT-18-06 使用优化的纳洛酮分配策略预防和救援芬太尼和其他阿片类药物过量(PROFOUND)
  • 批准号:
    10588267
  • 财政年份:
    2019
  • 资助金额:
    $ 29.33万
  • 项目类别:
The Rhode Island Young Adult Prescription and Illicit Drug Study (RAPIDS): Responding to Fentanyl and Associated Harms
罗德岛州青少年处方和非法药物研究 (RAPIDS):应对芬太尼及相关危害
  • 批准号:
    10162577
  • 财政年份:
    2019
  • 资助金额:
    $ 29.33万
  • 项目类别:
The Rhode Island Young Adult Prescription and Illicit Drug Study (RAPIDS): Responding to Fentanyl and Associated Harms
罗德岛州青少年处方和非法药物研究 (RAPIDS):应对芬太尼及相关危害
  • 批准号:
    10411973
  • 财政年份:
    2019
  • 资助金额:
    $ 29.33万
  • 项目类别:
The Rhode Island Young Adult Prescription and Illicit Drug Study (RAPIDS): Responding to Fentanyl and Associated Harms
罗德岛州青少年处方和非法药物研究 (RAPIDS):应对芬太尼及相关危害
  • 批准号:
    10629228
  • 财政年份:
    2019
  • 资助金额:
    $ 29.33万
  • 项目类别:
Core B: Data and Research Methods
核心 B:数据和研究方法
  • 批准号:
    10256005
  • 财政年份:
    2018
  • 资助金额:
    $ 29.33万
  • 项目类别:
Core B: Data and Research Methods
核心 B:数据和研究方法
  • 批准号:
    10006598
  • 财政年份:
    2018
  • 资助金额:
    $ 29.33万
  • 项目类别:
Exploring transitions to injecting among young adult non-medical opioid users
探索年轻成人非医疗阿片类药物使用者向注射的转变
  • 批准号:
    8845186
  • 财政年份:
    2014
  • 资助金额:
    $ 29.33万
  • 项目类别:
Exploring transitions to injecting among young adult non-medical opioid users
探索年轻成人非医疗阿片类药物使用者向注射的转变
  • 批准号:
    8731017
  • 财政年份:
    2014
  • 资助金额:
    $ 29.33万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.33万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.33万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.33万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.33万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.33万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.33万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.33万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.33万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.33万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.33万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了